Clinical Trials Logo

Periodontal Diseases clinical trials

View clinical trials related to Periodontal Diseases.

Filter by:

NCT ID: NCT04580355 Recruiting - Clinical trials for Periodontal Diseases

Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome

Start date: July 2021
Phase: Phase 4
Study type: Interventional

Periodontitis is an inflammatory disease characterized by a dysbiotic microbiome which can lead to bone destruction and tooth loss. Several studies had been reported the association to periodontal disease with systemic conditions and this relation suggests and axis that links oral and gut microbiome. In order to clarify the impact of periodontal condition on gut microbiome, we aim to evaluate the clinical, immunological parameters and the microbiological condition by sequencing of subgingival biofilm and stool samples both before and after non-surgical periodontal treatment with and without antibiotics as adjunct.

NCT ID: NCT04576468 Completed - Clinical trials for Periodontal Diseases

The Use of Leucocyte Platelet Rich Fibrin (L- PRF) Covered Perforated Guided Tissue Membrane for Treatment of Periodontal Intrabony Defects

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

This study is the first to investigate the effect of leucocyte platelet rich fibrin (L-PRF) combined with perforated membrane in order to treat infrabony defects and assess their combined effect in clinical attachment level gain and filling of base of the defect (BD). The main hypothesis was that if the L-PRF act as a chemoattracttant for a higher number of periosteal derived periodontal cells (PDPCs) and gingival mesenchymal stem cells (GMSCs) encouraging their passage through the membrane perforations.

NCT ID: NCT04567030 Recruiting - Clinical trials for Periodontal Diseases

Using Artificial Intelligence-platform on Plaque Control and Periodontal Treatment Outcome in Patients With Periodontal Disease-Preliminary Results

Start date: November 16, 2019
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the long-term effectiveness of an AI dental monitoring intervention on patients' periodontal disease, preventive behaviors and motivation. This randomized controlled trial included experimental group: AI group (EG-A), AI-humanized group (EG-B) and control group(CG), respectively. The EG-A and EG-B received AI dental monitoring intervention by taking mouth image at home once a week for six month. Baseline and follow-up surveys were used to collect the data in periodontal index, periodontal preventive behavior and motivation.

NCT ID: NCT04565691 Recruiting - Sepsis Clinical Trials

Bacteremia From Periodontal Treatment to Elucidate the Underpinnings of Sepsis

Start date: February 25, 2019
Phase: N/A
Study type: Interventional

Approximately 40,000 Swedes suffer from sepsiseach year, about 20% die. Biomarkers that are sensitive to current or previous bacteremia are needed in the treatment of sepsis. Bacteremia from periodontal treatment is predictive and occurs in 13-75%. Cardiovascular disease (CVD) is the number one cause of death in industrialized countries and the impact of bacteria and their products need to be elucidated. The study's hypothesis is to utilize bacteremia from periodontal treatment to evaluate biological markers for current or previous bacteremia. A. What are the long term clinical, and 'omics related CVD-phenotypical effects from treating periodontal disease compared to an untreated group? B. Can biomarkers be used for detecting a bacteremia or previous bacteremia? C. Are the effects from bacteremia on cardiovascular biomarkers related to the individual's antimicrobial peptide profile? D. Does the presence of bacterial proteases, such as gingipain, relate to having a bacteremia from periodontal treatment and the systemic response from a bacteremia? Significance: The project has the potential to shorten the time to treat sepsis, which in turn shortens hospital stay and higher survival. The possible definition of protective AMP-profile could translate to future pharmacologic intervention and improve the treatment of sepsis as well as prophylactic treatment at dental treatments. An elucidation of the impact of bacteria and their products on CVD could lead to personalized medicine targeting anti-inflammation and anti-oxidative stress in subjects with periodontitis. As of March 2024 78 subjects have been included and we anticipate to keep the time-line that we set up.

NCT ID: NCT04564950 Completed - Clinical trials for Periodontal Diseases

Influence of Periodontitis and Coronary Heart Disease on Galectin-3

Start date: April 1, 2016
Phase:
Study type: Observational

The aim of this study was to analyze the association between serum and salivary Galectin-3 levels in patients with periodontitis. Furthermore, the objective was to determine if the periodontitis influenced serum and salivary Galectin-3 levels

NCT ID: NCT04556708 Completed - Clinical trials for Periodontal Diseases

Ozonated Water Irrigation as an Adjunct to Periodontal Therapy

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

The use of chlorhexidine or ozonized water in periodontal pockets accompanying NPT can provide a significant improvement in probing pocket depths compared to conventional treatment. However, the effect of subgingival ozonized water applications on VEGF and IGF levels, which are thought to play a role in the pathogenesis of periodontal disease and periodontal regeneration, should be examined.

NCT ID: NCT04532255 Recruiting - Clinical trials for Periodontal Diseases

Periodontal Health Knowledge Among Patients With Fixed Orthodontic Appliance

Start date: October 2020
Phase:
Study type: Observational

The study is a cross-sectional survey investigating the Periodontal health knowledge among patients with fixed orthodontic appliance attending the orthodontic department and the paid section faculty of dentistry Cairo University. The faculty of Dentistry, Cairo University is an open public facility, a tertiary healthcare and a referral center.

NCT ID: NCT04530695 Withdrawn - Clinical trials for Acute Myelogenous Leukemia

Diagnosis and Treatment of Periodontal Disease in Patients With AML

Start date: May 2022
Phase: N/A
Study type: Interventional

This is a phase 2 randomized controlled trial of pre-chemotherapy periodontal deep cleaning in Acute Myelogenous Leukemia (AML) patients with asymptomatic periodontitis. Once eligibility is confirmed, participants with periodontitis will be randomized in a 1:1 ratio to undergo treatment by scaling and root planing (SRP, "deep cleaning") (arm A) or receive no periodontal treatment (arm B). We will compare the incidence of Blood Stream Infection (BSI) during chemotherapy between the two arms. Study participation will continue until day 28 of chemotherapy or discharge from hospital, whichever occurs first.

NCT ID: NCT04509505 Completed - Clinical trials for Periodontal Diseases

Effect of Waterpipe Smoking on Periodontal Health

Start date: November 1, 2020
Phase:
Study type: Observational

The main objective of the study is to assess the effect of waterpipe smoking on periodontal health, which will be done using a well constructed validated questionnaire. Then a full periodontal examination and x-ray evaluation will be done for all of the participants.

NCT ID: NCT04478864 Completed - Clinical trials for Periodontal Diseases

Knowledge, Practice and State of Periodontal Health

Start date: September 27, 2020
Phase:
Study type: Observational

The main objective of the study is to assess the knowledge and practice of periodontal health, which will be done using a well constructed and validated questionnaire. Then periodontal health status of all participants will be assessed via clinical examination of certain teeth.